Brian W. Ellis - 12 Nov 2025 Form 4 Insider Report for DANAHER CORP /DE/ (DHR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Nov 2025, 17:00:27 UTC
Prior SEC filing
03 Nov 2025
Next SEC filing
02 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ James F. O'Reilly, attorney-in-fact for Brian W. Ellis

Key filing fact

Brian W. Ellis filed Form 4 for DANAHER CORP /DE/ (DHR) on 13 Nov 2025.

Key facts

  • This page summarizes Brian W. Ellis's Form 4 filing for DANAHER CORP /DE/ (DHR).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 13 Nov 2025, 17:00.

Change

  • Previous filing in this sequence was filed on 03 Nov 2025.
  • Current net transaction value: -$3,498,007.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001662008 Primary reporting owner

Ellis Brian W

Relationship
Senior Vice President - GC
Address
2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON
Signature
/s/ James F. O'Reilly, attorney-in-fact for Brian W. Ellis
Signature date
13 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DHR transaction

Common Stock

Options Exercise

Transaction value
$416,516
Shares
+7,109
Change %
+49%
Price
$58.59
Shares after
21,662
Date
12 Nov 2025
Ownership
Direct
DHR transaction

Common Stock

Sale

Transaction value
$1,558,386
Shares
-7,109
Change %
-33%
Price
$219.21
Shares after
14,553
Date
12 Nov 2025
Ownership
Direct
DHR transaction

Common Stock

Options Exercise

Transaction value
$859,340
Shares
+14,667
Change %
+101%
Price
$58.59
Shares after
29,220
Date
12 Nov 2025
Ownership
Direct
DHR transaction

Common Stock

Sale

Transaction value
$3,215,477
Shares
-14,667
Change %
-50%
Price
$219.23
Shares after
14,553
Date
12 Nov 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DHR transaction Derivative

Employee stock option (right to buy)

Options Exercise

Transaction value
$0
Shares
-7,109
Change %
-100%
Price
$0.000000
Shares after
0
Date
12 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,109
Exercise price
$58.59
Footnotes
F2
DHR transaction Derivative

Employee stock option (right to buy)

Options Exercise

Transaction value
$0
Shares
-14,667
Change %
-100%
Price
$0.000000
Shares after
0
Date
12 Nov 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
14,667
Exercise price
$58.59
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.110 to $219.410, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Footnote F2

One fifth of the options granted became exercisable on each of the first five anniversaries of the grant date, which was February 24, 2016.

Footnote F3

Date shown is grant date. One third of the options granted became exercisable on each of the third, fourth and fifth anniversaries of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .